Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems
Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems

Author: Kamal Dua

Publisher: Academic Press

Published: 2020-08-04

Total Pages: 620

ISBN-13: 0128208880

DOWNLOAD EBOOK

Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems explores the development of novel therapeutics and diagnostics to improve pulmonary disease management, looking down to the nanoscale level for an efficient system of targeting and managing respiratory disease. The book examines numerous nanoparticle-based drug systems such as nanocrystals, dendrimers, polymeric micelles, protein-based, carbon nanotube, and liposomes that can offer advantages over traditional drug delivery systems. Starting with a brief introduction on different types of nanoparticles in respiratory disease conditions, the book then focuses on current trends in disease pathology that use different in vitro and in vivo models. The comprehensive resource is designed for those new to the field and to specialized scientists and researchers involved in pulmonary research and drug development. - Explores recent perspectives and challenges regarding the management and diagnosis of chronic respiratory diseases - Provides insights into how advanced drug delivery systems can be effectively formulated and delivered for the management of various pulmonary diseases - Includes the most recent information on diagnostic methods and treatment strategies using controlled drug delivery systems (including nanotechnology)

Controversies in COPD
Controversies in COPD

Author: Antonio Anzueto

Publisher: European Respiratory Society

Published: 2015-09-01

Total Pages: 341

ISBN-13: 1849840644

DOWNLOAD EBOOK

COPD is one of the most common diseases worldwide and is projected to be the third leading cause of death by 2020. But that does not mean it is easy to understand or manage. In everyday practice, pulmonologists face areas of controversy in COPD, for which evidence-based medicine is often unavailable. This ERS Monograph considers where the current controversies in COPD lie, discussing areas such as screening, premature birth, asthma–COPD overlap syndrome, treatment, rehabilitation and palliative care. This book will be of great interest to both clinicians and scientists, and aims to stimulate further discussion about this diverse and fascinating disease. "...contains a vast amount of information on the disease, its prevalence, signs and symptoms, diagnositc tests and treatment options. The book's format makes it quick and simple to find out what you need to know, and its size would make it easy to take to work for use in practice [...] invaluable for anyone working with patients with the disease." Emma Vincent, Nursing Standard

Drug Delivery to the Lung
Drug Delivery to the Lung

Author: Hans Bisgaard

Publisher: CRC Press

Published: 2001-10-02

Total Pages: 536

ISBN-13: 0824741978

DOWNLOAD EBOOK

This book focuses on the aerosol treatment of lung diseases, recent improvements in the understanding of proper dosage, and major innovations in device technology applied to clinical practice. Examines the behavior of inspired spherical particles in the respiratory tract!Featuring over 1300 references, drawings, tables, and photographs.

Inhaled Medicines
Inhaled Medicines

Author: Stavros Kassinos

Publisher: Academic Press

Published: 2021-02-05

Total Pages: 438

ISBN-13: 0128149744

DOWNLOAD EBOOK

Inhaled medicines are widely used to treat pulmonary and systemic diseases. The efficacy and safety of these medicines can be influenced by the deposited fraction, the regional deposition pattern within the lungs and by post-depositional events such as drug dissolution, absorption and clearance from the lungs. Optimizing performance of treatments thus requires that we understand and are able to quantify these product and drug attributes. Inhaled Medicines: Optimizing Development through Integration of In Silico, In Vitro and In Vivo Approaches explores the current state of the art with respect to inhalation drug delivery, technologies available to assess product performance, and novel in silico methods now available to link in vitro product performance to clinical performance. Recent developments in the latter field, especially the prospect of integration of three-dimensional Computational Fluid Particle Methods (3D-CFPD) with physiologically based pharmacokinetic (PBPK models), unlocks the potential for in silico population studies that can help inform and optimize treatment and product development strategies. In this highly multidisciplinary field, where progress occurs at the intersection of several disciplines of engineering and science, this work aims to integrate current knowledge and understanding and to articulate a clear vision for future developments. ? Considers the healthcare needs driving the field, and where inhaled drugs could have the maximum impact ? Gives a concise account of the state of the art in key areas and technologies such as device and formulation technologies, clinically relevant in vitro performance assessment, medical imaging, as well as in silico modelling and simulation ? Articulates how the combination of in vitro product performance data, medical imaging and simulations technologies in the framework of large scale in silico pre-clinical trials could revolutionize the field ? Provides systematic and thorough referencing to sources offering a more-in-depth analysis of technical issues

Breathe Easy
Breathe Easy

Author: Donald A. Mahler, MD

Publisher: University Press of New England

Published: 2017-06-06

Total Pages: 186

ISBN-13: 1512600806

DOWNLOAD EBOOK

Most people don't think about breathing; it is an automatic, unconscious act. However, the majority of those with asthma (26 million Americans); chronic obstructive pulmonary disease, or COPD (24 million Americans); or interstitial lung disease (1-2 million Americans) are aware of their shortness of breath because it interferes with work or other daily activities. As a result, these individuals seek medical attention for diagnosis and treatment. Breathe Easy, written by a pulmonologist, explains what constitutes normal breathing, what causes someone to feel short of breath, and what can be done to improve one's breathing. In chapters on asthma, COPD, and interstitial lung disease, Dr. Donald A. Mahler addresses the origins and treatments of these conditions, and offers advice for both standard and alternative therapies to breathe easy. Other chapters describe how we breathe, how to understand respiratory difficulties like chronic shortness of breath, the correct use of inhalers, the effects of aging on the brain and body, and the benefits of exercise. His final chapter provides valuable advice about traveling with oxygen. Illustrated with over fifty enlightening medical graphics, Breathe Easy offers a complete and compact guide for the millions of Americans who are limited by their breathing.

Inhaled Delivery Systems for the Treatment of Asthma and COPD
Inhaled Delivery Systems for the Treatment of Asthma and COPD

Author: Donald A. Mahler

Publisher: CRC Press

Published: 2023-07-19

Total Pages: 250

ISBN-13: 1000884449

DOWNLOAD EBOOK

Inhaled therapies form the cornerstone for treatment of patients with asthma and COPD. Evolving technology has resulted in availability of a wide range of devices for delivery of inhaled drugs. The four different delivery systems -- pressurized metered-dose inhalers, slow mist inhalers, dry powder inhalers, and nebulizers -- are unique in design and require distinct inhalational instructions for correct use. This book provides current information about inhalation devices, including their advantages and disadvantages, with guidance for optimal techniques of use. The book emphasizes appropriate selection of inhalation devices based on patient and health care professional factors as well as device attributes that allow selection of the right medication in the right inhalation device at the right time for the right patient. Key Features: • Addresses the objective of precision medicine – the right medication in the right inhaler device at the right time. • Inputs by international thought leaders who have published widely on inhaled medications and/or inhaled delivery systems for clinicians, trainees and respiratory therapists. • Discusses the development of audio-based systems and smart inhalers for patient monitoring.

Advances in Pulmonary Drug Delivery
Advances in Pulmonary Drug Delivery

Author: Philip Chi Lip Kwok

Publisher: CRC Press

Published: 2016-12-19

Total Pages: 201

ISBN-13: 131531195X

DOWNLOAD EBOOK

The respiratory tract has been used to deliver biologically active chemicals into the human body for centuries. However, the lungs are complex in their anatomy and physiology, which poses challenges to drug delivery. Inhaled formulations are generally more sophisticated than those for oral and parenteral administration. Pulmonary drug development is therefore a highly specialized area because of its many unique issues and challenges. Rapid progress is being made and offers novel solutions to existing treatment problems. Advances in Pulmonary Drug Delivery highlights the latest developments in this field.

Respiratory Drug Delivery (1989)
Respiratory Drug Delivery (1989)

Author: Peter R. Byron

Publisher: CRC Press

Published: 2018-04-20

Total Pages: 571

ISBN-13: 1351358014

DOWNLOAD EBOOK

The focus of this book is on subjects related to drug delivery to the lung. The text spans topics from aerosol deposition through pharmaceutical chemistry and formulation to the final clinical evaluation of pharmaceutical products. Utilizing a multi-disciplinary approach, the chapters consider toxicology from the point of view of drugs and pharmaceutical excipients used in aerosols.

Controlled Pulmonary Drug Delivery
Controlled Pulmonary Drug Delivery

Author: Hugh D.C. Smyth

Publisher: Springer Science & Business Media

Published: 2011-06-24

Total Pages: 560

ISBN-13: 1441997458

DOWNLOAD EBOOK

The pace of new research and level of innovation repeatedly introduced into the field of drug delivery to the lung is surprising given its state of maturity since the introduction of the pressurized metered dose inhaler over a half a century ago. It is clear that our understanding of pulmonary drug delivery has now evolved to the point that inhalation aerosols can be controlled both spatially and temporally to optimize their biological effects. These abilities include controlling lung deposition, by adopting formulation strategies or device technologies, and controlling drug uptake and release through sophisticated particle technologies. The large number of contributions to the scientific literature and variety of excellent texts published in recent years is evidence for the continued interest in pulmonary drug delivery research. This reference text endeavors to bring together the fundamental theory and practice of controlled drug delivery to the airways that is unavailable elsewhere. Collating and synthesizing the material in this rapidly evolving field presented a challenge and ultimately a sense of achievement that is hopefully reflected in the content of the volume.

A Nationwide Framework for Surveillance of Cardiovascular and Chronic Lung Diseases
A Nationwide Framework for Surveillance of Cardiovascular and Chronic Lung Diseases

Author: Institute of Medicine

Publisher: National Academies Press

Published: 2011-08-26

Total Pages: 200

ISBN-13: 0309212197

DOWNLOAD EBOOK

Chronic diseases are common and costly, yet they are also among the most preventable health problems. Comprehensive and accurate disease surveillance systems are needed to implement successful efforts which will reduce the burden of chronic diseases on the U.S. population. A number of sources of surveillance data-including population surveys, cohort studies, disease registries, administrative health data, and vital statistics-contribute critical information about chronic disease. But no central surveillance system provides the information needed to analyze how chronic disease impacts the U.S. population, to identify public health priorities, or to track the progress of preventive efforts. A Nationwide Framework for Surveillance of Cardiovascular and Chronic Lung Diseases outlines a conceptual framework for building a national chronic disease surveillance system focused primarily on cardiovascular and chronic lung diseases. This system should be capable of providing data on disparities in incidence and prevalence of the diseases by race, ethnicity, socioeconomic status, and geographic region, along with data on disease risk factors, clinical care delivery, and functional health outcomes. This coordinated surveillance system is needed to integrate and expand existing information across the multiple levels of decision making in order to generate actionable, timely knowledge for a range of stakeholders at the local, state or regional, and national levels. The recommendations presented in A Nationwide Framework for Surveillance of Cardiovascular and Chronic Lung Diseases focus on data collection, resource allocation, monitoring activities, and implementation. The report also recommends that systems evolve along with new knowledge about emerging risk factors, advancing technologies, and new understanding of the basis for disease. This report will inform decision-making among federal health agencies, especially the Department of Health and Human Services; public health and clinical practitioners; non-governmental organizations; and policy makers, among others.